Literature DB >> 2527495

The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression.

R Horuk1, J A McCubrey.   

Abstract

In a previous paper [Horuk, Huang, Covington & Newton (1987) J. Biol. Chem. 262, 16275-16278] we reported that there were fundamental differences in the biochemical properties of the interleukin-1 (IL-1) receptor between Raji and EL4 cell lines. In the present study we have investigated the basis for these differences. Kinetic studies measuring the on and off rates of IL-1 receptor binding revealed that the low-affinity IL-1-binding sites observed in Raji cells, compared with EL4 cells, result from a combination of a lower association rate and a higher dissociation rate in the Raji cells. The turnover of the Raji IL-1 receptor, measured by inhibiting protein synthesis with cycloheximide, was much faster than that of the EL4 IL-1 receptor, with a half-time of 2 h as against 5 h. Treatment of 125I-IL-1-labelled IL-1 receptors in Raji and EL4 cells with neuraminidase decreased their molecular mass by approx. 2-5 kDa as assessed by SDS/polyacrylamide-gel electrophoresis (PAGE). The covalently labelled IL-1 receptors in both cell types were sensitive to treatment with endoglycosidase F, which decreased their molecular mass on SDS/PAGE by 12-13 kDa. Incubation of Raji cells with maximally stimulating doses of IL-1 resulted in an increase in the nascent RNA levels of several genes, including the IL-2 receptor and the proto-oncogenes c-Ha-ras and c-myc.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527495      PMCID: PMC1138728          DOI: 10.1042/bj2600657

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

Review 1.  Interleukin 1: an immunological perspective.

Authors:  S K Durum; J A Schmidt; J J Oppenheim
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

2.  Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.

Authors:  K Matsushima; T Akahoshi; M Yamada; Y Furutani; J J Oppenheim
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

3.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.

Authors:  W J Leonard; J M Depper; G R Crabtree; S Rudikoff; J Pumphrey; R J Robb; M Krönke; P B Svetlik; N J Peffer; T A Waldmann
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

4.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

Authors:  R J Robb; W C Greene; C M Rusk
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

5.  Similarity between the interleukin 1 receptors on a murine T-lymphoma cell line and on a murine fibroblast cell line.

Authors:  S K Dower; S M Call; S Gillis; D L Urdal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts.

Authors:  S B Mizel; P L Kilian; J C Lewis; K A Paganelli; R A Chizzonite
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

7.  The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.

Authors:  S K Dower; S R Kronheim; T P Hopp; M Cantrell; M Deeley; S Gillis; C S Henney; D L Urdal
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

8.  Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.

Authors:  P L Kilian; K L Kaffka; A S Stern; D Woehle; W R Benjamin; T M Dechiara; U Gubler; J J Farrar; S B Mizel; P T Lomedico
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

9.  Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells.

Authors:  T A Bird; J Saklatvala
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

10.  Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor.

Authors:  J W Lowenthal; H R MacDonald
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  6 in total

1.  High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

Authors:  S D Yanofsky; D N Baldwin; J H Butler; F R Holden; J W Jacobs; P Balasubramanian; J P Chinn; S E Cwirla; E Peters-Bhatt; E A Whitehorn; E H Tate; A Akeson; T L Bowlin; W J Dower; R W Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.

Authors:  C J van der Laken; O C Boerman; W J Oyen; M T van de Ven; R Chizzonite; F H Corstens; J W van der Meer
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

3.  Interleukin 1 signaling occurs exclusively via the type I receptor.

Authors:  J E Sims; M A Gayle; J L Slack; M R Alderson; T A Bird; J G Giri; F Colotta; F Re; A Mantovani; K Shanebeck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

Review 4.  Cytokines and reproduction.

Authors:  C Simón; M L Polan
Journal:  West J Med       Date:  1994-05

5.  Differences in internalization and intracellular processing of interleukin-1 associated with the two forms of interleukin-1 receptor found in B-cells and T-cells.

Authors:  R Horuk
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

6.  A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.

Authors:  C J McMahan; J L Slack; B Mosley; D Cosman; S D Lupton; L L Brunton; C E Grubin; J M Wignall; N A Jenkins; C I Brannan
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.